Your browser doesn't support javascript.
loading
CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis.
Laine, Anni; Nagelli, Srikar G; Farrington, Caroline; Butt, Umar; Cvrljevic, Anna N; Vainonen, Julia P; Feringa, Femke M; Grönroos, Tove J; Gautam, Prson; Khan, Sofia; Sihto, Harri; Qiao, Xi; Pavic, Karolina; Connolly, Denise C; Kronqvist, Pauliina; Elo, Laura L; Maurer, Jochen; Wennerberg, Krister; Medema, Rene H; Joensuu, Heikki; Peuhu, Emilia; de Visser, Karin; Narla, Goutham; Westermarck, Jukka.
Afiliação
  • Laine A; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Nagelli SG; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Farrington C; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Butt U; Institute of Biomedicine, University of Turku, Turku, Finland.
  • Cvrljevic AN; Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
  • Vainonen JP; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
  • Feringa FM; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Grönroos TJ; Institute of Biomedicine, University of Turku, Turku, Finland.
  • Gautam P; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Khan S; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Sihto H; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Qiao X; Turku PET Center, University of Turku, Turku, Finland.
  • Pavic K; Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland.
  • Connolly DC; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Kronqvist P; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Elo LL; Department of Pathology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
  • Maurer J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Wennerberg K; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Medema RH; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Joensuu H; Institute of Biomedicine, University of Turku, Turku, Finland.
  • Peuhu E; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • de Visser K; Institute of Biomedicine, University of Turku, Turku, Finland.
  • Narla G; Department of Obstetrics and Gynecology, University Hospital Aachen (UKA), Aachen, Germany.
  • Westermarck J; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
Cancer Res ; 81(16): 4319-4331, 2021 08 15.
Article em En | MEDLINE | ID: mdl-34145035
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoantígenos / Neoplasias da Mama / Proteínas Nucleares / Proteínas de Transporte / Peptídeos e Proteínas de Sinalização Intracelular / Proteínas de Ligação a DNA / Carcinogênese / Proteínas de Membrana Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoantígenos / Neoplasias da Mama / Proteínas Nucleares / Proteínas de Transporte / Peptídeos e Proteínas de Sinalização Intracelular / Proteínas de Ligação a DNA / Carcinogênese / Proteínas de Membrana Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article